• Germany is ready to authorize the delivery of Eurofighter (BAE Systems, Airbus, Leonardo) to Saudi Arabia, according to Reuters.
  • The US Department of Justice is about to file an antitrust complaint against Apple.
  • Harris calls for the break-up of Bayer, in which he holds a 4% stake.
  • Pandora exceeds its sales and earnings forecasts thanks to a solid fourth quarter.
  • Synopsys is in advanced talks to acquire Ansys for $35 billion, according to the WSJ.
  • Southwestern Energy and Chesapeake Energy are close to a merger, according to the WSJ.
  • CMC Markets raises its operating profit forecast.
  • Merck in talks to buy Harpoon Therapeutics for around $700 million, according to Bloomberg.
  • Honda plans $14 billion project to produce electric vehicles in Canada, according to Nikkei.
  • Novartis partners with Isomorphic Labs (Alphabet) for AI-driven drug discovery.
  • Berkshire Hathaway settles valuation dispute with Pilot.
  • Some of BP Plc's major shareholders have asked the company to approach BAE Systems managing director Charles Woodburn to become the next CEO, according to Sky News.
  • The vice-president of China Evergrande Group's EV unit, China Evergrande New Energy, was arrested in China.
  • Vinfast plans to invest $2 billion in India. Vinfast appointed its founder and main backer, Pham Nhat Vuong, as CEO on Saturday, as the company plans overseas expansion and increased sales through dealerships.
  • Danube wants to buy the last DSM shares at EUR 96 each.
  • SoftwareOne confirms talks with Bain.
  • Capital A sells its aeronautical activities to AirAsia X.
  • Swisscom to cease web hosting business.
  • EQT to build and operate data centers for large-scale customers.
  • Alcon and Lifecore Biomedical extend contract manufacturing agreement.
  • Boeing fell by 8.3% before the opening after Friday's incident involving one of its 737 MAX 9 models.
  • Apple - iPhone sales in China fell 30% in the first week of 2024, write Jefferies analysts in a note.
  • BlackRock will reduce its global workforce by around 3%, according to Fox Business.
  • Nvidia plans to start production of its artificial intelligence chip for the Chinese market in the second quarter of 2024, two sources familiar with the matter said on Monday.
  • Boston Scientific announced Monday that it had acquired Axonics for $3.7 billion.
  • Moderna on Monday reported preliminary 2023 sales of $6.7 billion for its COVID-19 vaccine, above the lower end of its full-year guidance.
  • Regeneron Pharmaceuticals said Monday that its ophthalmic treatment Eylea had recorded preliminary U.S. fourth-quarter sales of $1.34 billion.
  • Allison Transmission - The United Auto Workers (UAW) union reached agreement with the auto parts manufacturer on a tentative deal covering 1,500 workers in Indianapolis, the labor organization said Friday.
  • Harpoon Therapeutics doubles its share price to $21.10 before the open, as Merck is in advanced talks to buy the group for around $700 million, or $23 per share, Bloomberg News reports.
  • Ligand Pharmaceuticals rises 5.2% ahead of opening after its topical treatment for viral skin infection receives FDA approval.
  • Cellectar Biosciences said Monday that its treatment for a type of blood cancer had met its primary endpoint in a clinical trial.
  • Metagenomi Technologies, a genetic drug company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the US on Friday.